Please login to the form below

Not currently logged in
Email:
Password:

Wixela Inhub

This page shows the latest Wixela Inhub news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • GSK’s Advair Diskus faces first generic in US GSK’s Advair Diskus faces first generic in US

    Analysts predict around $250m in sales for Wixela Inhub this year. ... Mylan’s version of the drug is called Wixela Inhub and it has made it to the market ahead of rivals from the likes of Novartis’ Sandoz unit and Hikma/Vectura,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics